BioPharma Dive ٢٨ يناير ٢٠٢٦ Lilly bets on Seamless, delving further into genetic medicine for hearing loss
BioPharma Dive ١٤ يناير ٢٠٢٦ Lilly, chasing Novo, expects second-quarter FDA decision on obesity pill
BioPharma Dive ١٨ ديسمبر ٢٠٢٥ Lilly obesity pill, headed for quick FDA review, hits mark in ‘maintenance’ trial